Fisher Asset Management LLC decreased its stake in Parexel International Corp. (NASDAQ:PRXL) by 1.1% during the third quarter, according to its most recent filing with the SEC. The fund owned 2,312,019 shares of the company’s stock after selling 24,983 shares during the period. Fisher Asset Management LLC owned about 4.35% of Parexel International Corp. worth $160,570,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Aristotle Capital Boston LLC raised its position in Parexel International Corp. by 3.5% in the second quarter. Aristotle Capital Boston LLC now owns 156,770 shares of the company’s stock valued at $9,858,000 after buying an additional 5,298 shares in the last quarter. Metropolitan Life Insurance Co. NY raised its position in Parexel International Corp. by 4.1% in the first quarter. Metropolitan Life Insurance Co. NY now owns 86,769 shares of the company’s stock valued at $5,443,000 after buying an additional 3,389 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Parexel International Corp. by 1.2% in the second quarter. Dimensional Fund Advisors LP now owns 908,947 shares of the company’s stock valued at $57,150,000 after buying an additional 11,098 shares in the last quarter. Geode Capital Management LLC raised its position in Parexel International Corp. by 7.2% in the first quarter. Geode Capital Management LLC now owns 404,974 shares of the company’s stock valued at $25,404,000 after buying an additional 27,205 shares in the last quarter. Finally, Aberdeen Asset Management PLC UK raised its position in Parexel International Corp. by 25.3% in the second quarter. Aberdeen Asset Management PLC UK now owns 998,811 shares of the company’s stock valued at $62,806,000 after buying an additional 201,812 shares in the last quarter. 96.13% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Parexel International Corp. (NASDAQ:PRXL)

Parexel International Corp. (NASDAQ:PRXL) traded up 0.44% during mid-day trading on Monday, reaching $57.51. 3,756,636 shares of the company’s stock were exchanged. Parexel International Corp. has a 52-week low of $51.16 and a 52-week high of $71.13. The company has a 50-day moving average of $63.11 and a 200-day moving average of $64.19. The stock has a market cap of $3.06 billion, a price-to-earnings ratio of 18.14 and a beta of 0.91.

Parexel International Corp. (NASDAQ:PRXL) last released its quarterly earnings data on Wednesday, October 26th. The company reported $0.76 earnings per share for the quarter, missing analysts’ consensus estimates of $0.86 by $0.10. Parexel International Corp. had a net margin of 7.09% and a return on equity of 30.71%. The business earned $500.90 million during the quarter, compared to the consensus estimate of $525.15 million. During the same period last year, the business posted $0.70 earnings per share. The firm’s quarterly revenue was down 2.2% on a year-over-year basis. Equities research analysts anticipate that Parexel International Corp. will post $3.78 earnings per share for the current year.

Several research analysts have recently weighed in on the stock. First Analysis lowered shares of Parexel International Corp. from an “overweight” rating to an “equal weight” rating and set a $62.00 price objective on the stock. in a research note on Thursday. Credit Suisse Group AG restated a “buy” rating on shares of Parexel International Corp. in a research note on Wednesday, November 16th. SunTrust Banks Inc. lowered shares of Parexel International Corp. from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $80.00 to $60.00 in a research note on Friday, November 11th. Zacks Investment Research upgraded shares of Parexel International Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday, November 1st. Finally, Evercore ISI restated a “buy” rating and set a $70.00 price objective (down from $79.00) on shares of Parexel International Corp. in a research note on Saturday, October 29th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $67.00.

About Parexel International Corp.

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology and medical device industries across the world.

5 Day Chart for NASDAQ:PRXL

Receive News & Stock Ratings for Parexel International Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parexel International Corp. and related stocks with our FREE daily email newsletter.